Daniel Lee Flynn, Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 296,112 shares at $48.00 ($14.2M) on 2019-11-08, disclosed to the SEC on 2019-11-13.
Open-market sale of $14.2M DCPH by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.00 | 9,742 | $468K | 3.3% |
| 2 | $48.01 | 143,185 | $6.9M | 48.4% |
| 3 | $48.01 | 143,185 | $6.9M | 48.4% |
| Total | $48.01 avg | 296,112 | $14.2M | 100% |
| Filing → |
| DCPH | SELL | 2023-01-19 | $102K | — | Filing → |
| DCPH | SELL | 2022-06-21 | $19K | — | Filing → |
| DCPH | SELL | 2022-02-18 | $12K | — | Filing → |